CN100348718C - Culture medium without animal originating component and serum for HEK293 cell adhesion culture - Google Patents
Culture medium without animal originating component and serum for HEK293 cell adhesion culture Download PDFInfo
- Publication number
- CN100348718C CN100348718C CNB2005101090504A CN200510109050A CN100348718C CN 100348718 C CN100348718 C CN 100348718C CN B2005101090504 A CNB2005101090504 A CN B2005101090504A CN 200510109050 A CN200510109050 A CN 200510109050A CN 100348718 C CN100348718 C CN 100348718C
- Authority
- CN
- China
- Prior art keywords
- serum
- medium
- culture
- cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种支持HEK293细胞贴附培养的无动物来源成分无血清培养基。该无血清培养基由F12培养基和胰岛素、氨基酸、单糖及双糖、微量元素、CaCl2、透明质酸、金精三羧酸、乙醇胺、酵母水解物、羟丙基-β-环状糊精等培养基添加成分组成。本发明提供的无血清培养基具有以下优点:①能够支持HEK293细胞在组织培养瓶和微载体的表面贴附生长。②不含动物来源成分、化学成分基本明确。③细胞生长良好,细胞的培养密度、活率与含血清的培养基基本相同。④成本低廉。
The invention discloses a serum-free culture medium without animal-derived components and supporting the attachment culture of HEK293 cells. The serum-free medium consists of F12 medium and insulin, amino acids, monosaccharides and disaccharides, trace elements, CaCl 2 , hyaluronic acid, aurintricarboxylic acid, ethanolamine, yeast hydrolyzate, hydroxypropyl-β-cyclic Composition of dextrin and other medium additives. The serum-free medium provided by the present invention has the following advantages: ① It can support the attached growth of HEK293 cells on the surface of tissue culture flasks and microcarriers. ②It does not contain animal-derived ingredients, and the chemical composition is basically clear. ③The cells grow well, and the culture density and viability of the cells are basically the same as those in the medium containing serum. ④ low cost.
Description
技术领域technical field
本发明涉及一种支持哺乳动物细胞培养的无血清培养基,更具体地说是支持HEK293细胞贴附培养的无动物来源成分无血清培养基,属于细胞工程技术领域。The invention relates to a serum-free medium supporting the culture of mammalian cells, more specifically a serum-free medium supporting the attachment culture of HEK293 cells without animal-derived components, belonging to the technical field of cell engineering.
背景技术Background technique
动物细胞培养是生命科学研究和生物技术应用的关键技术体系。培养基(medium)是决定体外培养细胞生长代谢的最直接、最重要的环境因素。根据培养基使用中是否需要补充动物血清,可将动物细胞培养基大致可划分为合成培养基和无血清培养基(serum freemedium)。Animal cell culture is a key technical system for life science research and biotechnology applications. Medium is the most direct and important environmental factor that determines the growth and metabolism of cells cultured in vitro. According to whether animal serum needs to be supplemented in the use of the medium, animal cell culture medium can be roughly divided into synthetic medium and serum free medium.
自1950年Morgan等研制的199培养基问世以来,针对不同细胞类型的商品化合成培养基至少已有20余种之多,其中包括EMEM、αMEM、DMEM、IMEM、F12和RPMI 1640等被广泛使用的合成培养基。合成培养基的组成成分一般多达50余种,主要包括碳水化合物、氨基酸、维生素、核酸衍生物、脂类和无机盐等。合成培养基的使用特点是,一般仅能短期维持细胞的生存,需在其中补充5-20%(v/v)的动物血清才能支持体外培养细胞的生长、增殖。由于动物血清的成分十分复杂,其中仅蛋白质的种类就多达500余种。在生命科学研究中,常因动物血清的加入而干扰实验结果、影响细胞的功能和表型。从动物细胞表达产品的生产工艺角度考虑,动物血清批次间的质量差异可造成动物细胞表达产品生产的不稳定性,动物血清中的蛋白组分增加了重组蛋白纯化和质量控制的困难;从动物细胞表达产品的安全性考虑,动物血清的使用带来了动物源性病原微生物污染产品的可能。Since the advent of the 199 medium developed by Morgan et al. in 1950, there have been at least 20 commercial synthetic mediums for different cell types, including EMEM, αMEM, DMEM, IMEM, F12 and RPMI 1640, which are widely used. synthetic media. The composition of synthetic medium is generally as many as 50 kinds, mainly including carbohydrates, amino acids, vitamins, nucleic acid derivatives, lipids and inorganic salts. The characteristic of the use of synthetic medium is that it can generally only maintain the survival of cells for a short period of time, and it needs to be supplemented with 5-20% (v/v) animal serum to support the growth and proliferation of in vitro cultured cells. Due to the complex composition of animal serum, there are more than 500 types of proteins alone. In life science research, the addition of animal serum often interferes with experimental results and affects cell function and phenotype. From the perspective of the production process of animal cell expression products, the quality difference between batches of animal serum can cause instability in the production of animal cell expression products, and the protein components in animal serum increase the difficulty of recombinant protein purification and quality control; from Considering the safety of animal cell expression products, the use of animal serum brings the possibility of animal-derived pathogenic microorganisms contaminating the product.
1976年Hayashi和Sato首次报道在合成培养基中加入激素后能支持体外培养细胞的生长,由此揭开了动物细胞无血清培养基研究和应用的序幕。20世纪80年代后期以来,随着来人们对体外培养细胞代谢和生理学了解的不断深入、调控细胞生长代谢和分化的细胞因子种类及来源的丰富,商品化的无血清培养基无论在数量上和质量上都有明显的提高,无血清培养基已在生命科学的诸多研究领域和生物技术药物的规模化生产得于广泛应用。In 1976, Hayashi and Sato reported for the first time that adding hormones to synthetic medium could support the growth of cultured cells in vitro, which opened the prelude to the research and application of serum-free medium for animal cells. Since the late 1980s, as people have deepened their understanding of cell metabolism and physiology in vitro, and the types and sources of cytokines that regulate cell growth, metabolism, and differentiation have become more abundant, commercial serum-free media have been commercialized in terms of quantity and quality. The quality has been significantly improved, and serum-free medium has been widely used in many research fields of life sciences and large-scale production of biotechnology drugs.
HEK293细胞(human embryonic kidney 293 cells)为来源于经5型腺病毒转化的人胚肾上皮样细胞系,是贴附依赖性生长的连续传代细胞。在生命科学研究中,HEK293细胞被广泛用作研究细胞生物学和功能基因组学的细胞模型。近年来,随着生物技术药物产业化的发展和基因治疗研究的不断深入,HEK293细胞作为重组蛋白药物生产的表达系统和重组病毒载体的主要生产细胞的重要性日益显现。HEK293 cells (human embryonic kidney 293 cells) are derived from the human embryonic kidney epithelial-like cell line transformed by
文献报道的HEK293细胞无血清培养基只能支持HEK293细胞的悬浮培养,而且在培养基中加入了牛血清白蛋白(bovine serum albumin,BSA)等动物来源的添加成分。含BSA的无血清培养基在很大程度上遗留着动物来源血清在动物细胞培养的应用中可能产生的上述问题。美国Invitrogen公司开发的商品化无蛋白培养基(CD 293 medium)也只适用于HEK293细胞的悬浮培养。迄今为止,国内外均未见有关支持HEK293细胞贴附培养的无动物来源成分无血清培养基的报道。The serum-free medium for HEK293 cells reported in the literature can only support the suspension culture of HEK293 cells, and animal-derived additives such as bovine serum albumin (bovine serum albumin, BSA) are added to the medium. The serum-free medium containing BSA largely retains the above-mentioned problems that may arise from the application of animal-derived serum in animal cell culture. The commercial protein-free medium (CD 293 medium) developed by Invitrogen in the United States is only suitable for the suspension culture of HEK293 cells. So far, there are no reports on animal-derived component-free serum-free medium that supports the adherent culture of HEK293 cells at home and abroad.
HEK293细胞的悬浮培养不利于通过培养基的连续灌注操作为细胞的生长和代谢提供充足的营养成分并有效地控制有害细胞代谢产物的积累,从而达到提高细胞培养密度和细胞代谢效率的动物细胞表达产品生产过程优化的目的。另一方面,HEK293细胞的悬浮改变了HEK293细胞贴壁依赖性生长的原本体外培养特性,既影响到HEK293细胞体外培养的细胞表型,也对以HEK293细胞为细胞模型的细胞生物学和功能基因组学研究产生不可避免的干扰。Suspension culture of HEK293 cells is not conducive to providing sufficient nutrients for cell growth and metabolism through continuous perfusion of the medium and effectively controlling the accumulation of harmful cell metabolites, thereby achieving animal cell expression that improves cell culture density and cell metabolism efficiency The purpose of product production process optimization. On the other hand, the suspension of HEK293 cells changed the original in vitro culture characteristics of HEK293 cell anchorage-dependent growth, which not only affected the cell phenotype of HEK293 cells cultured in vitro, but also affected the cell biology and functional genome of HEK293 cells as cell models. unavoidable disruptions to scientific research.
发明内容Contents of the invention
本发明的目的在于提供一种适用于HEK293细胞体外培养的无血清培养基,该培养基具有不含动物来源成分、能支持HEK293细胞贴附依赖性生长和高密度化培养的特点。The purpose of the present invention is to provide a serum-free medium suitable for culturing HEK293 cells in vitro, which has the characteristics of not containing animal-derived components, and can support the attachment-dependent growth and high-density culture of HEK293 cells.
本发明采用的构思在于:1).合成培养基的配方均不是针对HEK293细胞而设计的,虽然其能基本满足HEK293细体外胞培养的营养需求,但其中的碳水化合物、氨基酸和无机盐等成份仍存在较大的调整和优化空间;2).合成培养基中缺少能支持动物细胞贴附培养的组成成分,不能直接用于支持动物细胞贴附培养。基于以上考虑,本发明的无血清培养基在F12培养基中加入了以下成分;The idea adopted in the present invention is: 1). None of the formulations of the synthetic medium is designed for HEK293 cells. Although it can basically meet the nutritional requirements of HEK293 cells in vitro, the components such as carbohydrates, amino acids and inorganic salts therein There is still a large room for adjustment and optimization; 2). The synthetic medium lacks components that can support animal cell attachment culture, and cannot be directly used to support animal cell attachment culture. Based on the above considerations, the serum-free medium of the present invention has added the following components in the F12 medium;
(1)胰岛素:促进细胞对葡萄糖和氨基酸的摄取、促进细胞生长。(1) Insulin: promotes the uptake of glucose and amino acids by cells, and promotes cell growth.
(2)氨基酸:培养基中氨基酸的浓度通常限制着细胞生长所能达到的最大密度及细胞活力状态,不同细胞对氨基酸的需求可能存在明显的差别,这些氨基酸既包括特定细胞类型不能合成的必需氨基酸,也包括细胞能够合成、但消耗速率大于细胞合成能力的非必需氨基酸。(2) Amino acids: The concentration of amino acids in the medium usually limits the maximum density and cell viability that can be achieved by cell growth. There may be significant differences in the requirements of different cells for amino acids. These amino acids include essential amino acids that cannot be synthesized by specific cell types. Amino acids also include non-essential amino acids that cells can synthesize but consume at a rate greater than the cell's synthetic capacity.
(3)单糖和双糖:果糖可部分地替代葡萄糖作为细胞生长代谢的能量来源之一、减少培养基中因葡萄糖无氧酵解产生的乳酸堆积。海藻糖是由两个葡萄糖分子结合而成的非还原性双糖,对激素、生长因子和酶等生物大分子具有非特异的保护作用,也可作为细胞代谢的能源物质。(3) Monosaccharides and disaccharides: Fructose can partially replace glucose as one of the energy sources for cell growth and metabolism, and reduce the accumulation of lactic acid in the medium due to anaerobic glycolysis of glucose. Trehalose is a non-reducing disaccharide formed by combining two glucose molecules. It has non-specific protective effects on biological macromolecules such as hormones, growth factors and enzymes, and can also be used as an energy source for cell metabolism.
(4)微量元素:Cu、Fe、Se和Ze等微量元素,主要作为酶的辅基参与细胞代谢的调节。其中:(4) Trace elements: trace elements such as Cu, Fe, Se and Ze are mainly used as prosthetic groups of enzymes to participate in the regulation of cell metabolism. in:
Cu:超氧化物岐化酶的辅基、具有抗氧化的作用。Cu: prosthetic group of superoxide dismutase, has anti-oxidation effect.
Fe:细胞色素酶、过氧化氢酶、过氧化物酶等和血红素的辅基,参与线粒体呼吸链的组成。Fe: Cytochrome, catalase, peroxidase, etc. and the prosthetic group of heme, participating in the composition of the mitochondrial respiratory chain.
Se:谷胱甘肽还原酶的组成部分、具有抗氧化的作用。Se: A component of glutathione reductase, which has an antioxidant effect.
Ze:作为酶的辅基与200多种酶的活性或结构有关,参与细胞生长、蛋白质合成和核酸代谢的调控。Ze: As the prosthetic group of enzymes, it is related to the activity or structure of more than 200 enzymes, and participates in the regulation of cell growth, protein synthesis and nucleic acid metabolism.
(5)Ca:构成细胞间质的重要成分,通过作用于细胞膜表面的钙粘着蛋白和整联蛋白介导细胞的黏附和伸展。(5) Ca: An important component of the intercellular substance, which mediates cell adhesion and extension by acting on cadherin and integrin on the surface of the cell membrane.
(6)透明质酸:细胞外基质成分,提供细胞生长和黏附的环境和基架。(6) Hyaluronic acid: an extracellular matrix component that provides an environment and a scaffold for cell growth and adhesion.
(7)金精三羧酸:金属鳌合剂,具有结合、运输和传递Fe2+,部分地替代铁转运蛋白的功能,同时也能通过结合和运输Ca2+促进细胞的黏附和伸展。(7) Aurintricarboxylic acid: a metal chelating agent, capable of binding, transporting and transferring Fe 2+ , partially replacing the function of iron transporter, and also promoting cell adhesion and extension by binding and transporting Ca 2+ .
(8)乙醇胺:磷脂和细胞膜合成的前体物质,对细胞的生长具有一定的促进作用。(8) Ethanolamine: a precursor substance for the synthesis of phospholipids and cell membranes, which can promote the growth of cells to a certain extent.
(9)酵母水解物:为细胞的生长提供氨基酸和维生素等营养成分、促进细胞生长。(9) Yeast hydrolyzate: provide nutrients such as amino acids and vitamins for cell growth, and promote cell growth.
(10)羟丙基-β-环状糊精:贮存和运送生物大分子,提高生物活性物质的稳定性和生物利用度。(10) Hydroxypropyl-β-cyclodextrin: store and transport biological macromolecules, improve the stability and bioavailability of biologically active substances.
根据以上发明构思,本发明在F12培养基的基础上,将上述物质按以下浓度(mg/L)加入到培养基中,组成了一种新的HEK293细胞无血清培养基(表1)。According to above inventive concept, the present invention is on the basis of F12 medium, adds above-mentioned substance in the medium by following concentration (mg/L), forms a kind of new HEK293 cell serum-free medium (Table 1).
表1支持HEK293细胞贴附培养的无动物来源成分无血清培养基Table 1 Animal-derived component-free serum-free medium supporting HEK293 cell-attached culture
以上无血清培养基组成成分均为商品化的化学/生物化学试剂,其供应商和型号如下:The components of the above serum-free medium are commercial chemical/biochemical reagents, and their suppliers and models are as follows:
F12培养基为美国GIBCO BRL公司的粉状制剂产品,商品号为:21700-075。F12 medium is a powder preparation product of GIBCO BRL Company in the United States, and the product number is 21700-075.
胰岛素为美国Sigma公司用E.Coli表达的重组产品,商品号为:I0259。Insulin is a recombinant product expressed by E. Coli from Sigma Company of the United States, and the product number is: I0259.
谷氨酰胺为美国GIBCO BRL公司的粉状制剂产品,商品号为:21051-040。Glutamine is a powder preparation product of GIBCO BRL Company in the United States, and the commodity number is: 21051-040.
脯氨酸为美国Sigma公司的粉状制剂产品,商品号为:P0380。Proline is a powder preparation product of Sigma Company in the United States, and the product number is: P0380.
精氨酸为美国Sigma公司的粉状制剂产品,商品号为:A4474。Arginine is a powder preparation product of Sigma Company in the United States, and the commodity number is: A4474.
丝氨酸为美国Sigma公司的粉状制剂产品,商品号为:S4311。Serine is a powder preparation product of Sigma Company in the United States, and the product number is: S4311.
天冬酰胺为美国Sigma公司的粉状制剂产品,商品号为:A4284。Asparagine is a powder preparation product of Sigma Company in the United States, and the commodity number is: A4284.
果糖为美国Sigma公司的粉状制剂产品,商品号为:F3510。Fructose is a powder preparation product of Sigma Company in the United States, and the product number is: F3510.
海藻糖为南宁中诺生物工程有限公司的医用级粉状制剂产品。Trehalose is a medical grade powder preparation product of Nanning Zhongnuo Biological Engineering Co., Ltd.
CuSO4·5H2O为美国Sigma公司的粉状制剂产品,商品号为:C8027。CuSO 4 ·5H 2 O is a powder preparation product of Sigma Company in the United States, and the product number is: C8027.
FeSO4·7H2O为美国Sigma公司的粉状制剂产品,商品号为:F8633。FeSO 4 ·7H 2 O is a powder preparation product of Sigma Company in the United States, and the product number is F8633.
Na2SeO3为美国Sigma公司的粉状制剂产品,商品号为:S1382。Na 2 SeO 3 is a powder preparation product of Sigma Company in the United States, and the product number is: S1382.
ZnSO4·7H2O为美国Sigma公司的粉状制剂产品,商品号为:Z0251。ZnSO 4 ·7H 2 O is a powder preparation product of Sigma Company in the United States, and the product number is: Z0251.
CaCl2为美国Sigma公司的粉状制剂产品,商品号为:C7902。CaCl 2 is a powder preparation product of Sigma Company in the United States, and the product number is: C7902.
透明质酸为山东正大福瑞达制药有限公司的医用级粉状制剂产品。Hyaluronic acid is a medical-grade powder preparation product of Shandong Zhengda Freda Pharmaceutical Co., Ltd.
金精三羧酸为美国Sigma公司的粉状制剂产品,商品号为:A1895。Aurine tricarboxylic acid is a powder preparation product of Sigma Company in the United States, and the commodity number is: A1895.
乙醇胺为美国Sigma公司的液体制剂产品,商品号为:E0135。Ethanolamine is a liquid preparation product of Sigma Company in the United States, and the product number is: E0135.
酵母水解物为美国Sigma公司的粉状制剂产品,商品号为:Y0500。Yeast hydrolyzate is a powder preparation product of Sigma Company in the United States, and the product number is: Y0500.
羟丙基-β-环状糊精为杭州正佳化学有限公司的医用级粉状制剂产品。Hydroxypropyl-β-cyclodextrin is a medical-grade powder preparation product of Hangzhou Zhengjia Chemical Co., Ltd.
本发明提供的无血清培养基与现有HEK293细胞无血清培养基相比具有以下优点:①能够支持HEK293细胞在组织培养瓶和微载体的表面贴附生长。②不含动物来源成分、化学成分基本明确。③细胞生长良好,细胞的培养密度和活率与含血清合成培养基本相同。Compared with the existing serum-free medium for HEK293 cells, the serum-free medium provided by the present invention has the following advantages: ① It can support the attached growth of HEK293 cells on the surface of tissue culture flasks and microcarriers. ②It does not contain animal-derived ingredients, and the chemical composition is basically clear. ③The cells grow well, and the culture density and viability of the cells are basically the same as those of the synthetic culture containing serum.
④成本低廉。④ low cost.
下面将结合附图和实施例,对本发明作进一步说明。The present invention will be further described below in conjunction with the accompanying drawings and embodiments.
附图说明Description of drawings
图1A为倒置显微镜下观察的、在本发明无血清培养基中生长的HEK293细胞;图1B为倒置显微镜下观察到的、在含血清培养基中生长的HEK293细胞。Figure 1A shows HEK293 cells grown in the serum-free medium of the present invention observed under an inverted microscope; Figure 1B shows HEK293 cells grown in serum-containing medium observed under an inverted microscope.
图2为HEK293细胞分别在本发明无血清培养基中和含血清培养基中培养的细胞密度变化。无血清培养基中培养的HEK293细胞密度(○);含5%(v/v)小牛血清F12培养基中培养的HEK293细胞密度(▲)。Figure 2 shows the changes in cell density of HEK293 cells cultured in the serum-free medium and the serum-containing medium of the present invention respectively. Density of HEK293 cells cultured in serum-free medium (○); density of HEK293 cells cultured in F12 medium containing 5% (v/v) calf serum (▲).
图3为在5L搅拌罐式生物反应器中用无血清培养基培养HEK293细胞的细胞密度和活力变化。Figure 3 shows the changes in cell density and viability of HEK293 cells cultured in a 5L stirred tank bioreactor with serum-free medium.
图4为HEK293细胞在5L搅拌罐式生物反应器中用无血清培养基培养所形成的细胞团。Figure 4 shows the cell mass formed by HEK293 cells cultured in a 5L stirred tank bioreactor with serum-free medium.
具体实施方式Detailed ways
实施例1、在100ml组织培养瓶中贴附培养HEK293细胞
将表2所列培养基成分定溶于1000ml去离子水中,室温下搅拌30min,使其充分溶解。用0.2μm滤膜过滤除菌后,置4℃冰箱保存。Dissolve the medium components listed in Table 2 in 1000ml deionized water, and stir at room temperature for 30min to fully dissolve. After sterilizing by filtration with a 0.2 μm filter membrane, store in a refrigerator at 4°C.
表2在100ml组织培养瓶中培养HEK293细胞的无血清培养基Table 2 Serum-free medium for culturing HEK293 cells in 100ml tissue culture flasks
将在100ml组织培养瓶中用无血清培养基培养的HEK293细胞(购自美国Invitrogen公司)用0.25%(w/v)的胰蛋白酶室温下消化2min。用无血清培养基清分散并调整细胞悬液浓度为2×105cells/ml,按10ml/瓶接种100ml组织培养瓶,每次接种7个培养瓶,37℃、5%CO2静止培养,用倒置显微镜观察细胞形态并拍照纪录。每天取其中的1瓶细胞经0.25%(w/v)胰蛋白酶消化处理后,用细胞密度和活力自动分析系统(Cedex A20,Innovatis)计数细胞密度。剩余细胞于培养的第2天起,根据培养基的颜色变化,每天按50~100%培养体积更换新鲜培养基。培养4天后,HEK293细胞形成致密单层,细胞形态呈现多角形上皮样细胞特征(图1A)。HEK293 cells (purchased from Invitrogen, USA) cultured in a 100 ml tissue culture flask with serum-free medium were digested with 0.25% (w/v) trypsin at room temperature for 2 min. Use serum-free medium to disperse and adjust the concentration of cell suspension to 2×10 5 cells/ml, inoculate 100 ml tissue culture flasks at 10 ml/bottle, inoculate 7 culture flasks each time, and culture statically at 37°C and 5% CO 2 , Cell morphology was observed with an inverted microscope and photographed for record. One flask of cells was taken every day and digested with 0.25% (w/v) trypsin, and then the cell density was counted with a cell density and viability automatic analysis system (Cedex A20, Innovatis). From the second day of culture, the remaining cells were replaced with fresh medium according to the color change of the medium at 50-100% of the culture volume every day. After 4 days of culture, HEK293 cells formed a dense monolayer, and the cell morphology showed characteristics of polygonal epithelioid cells (Fig. 1A).
将在100ml组织培养瓶中用含5%(v/v)小牛血清的F12培养基培养的HEK293细胞用0.25%(w/v)的胰蛋白酶室温下消化5min。用含5%(v/v)小牛血清的F12培养基无血清培养基分散并调整细胞悬液浓度为2×105cells/ml,按10ml/瓶接种100ml组织培养瓶,每次接种7个培养瓶,于37℃、5%CO2静止培养。除用含5%(v/v)小牛血清的F12培养基替代上述的无血清培养基外,HEK293细胞的培养和计数方法均与上述方法相同,以此作为实施例的对照。培养4天后,含5%(v/v)小牛血清F12培养基中的HEK293细胞形态与无血清培养基中培养的HEK293细胞相同(图1B)。HEK293细胞在无血清培养基中的生长动力学和细胞密度与其在作为实施例对照的含5%(v/v)小牛血清F12培养基中的培养效果相当(图2)。HEK293 cells cultured in a 100ml tissue culture flask with F12 medium containing 5% (v/v) calf serum were digested with 0.25% (w/v) trypsin at room temperature for 5 min. Disperse with serum-free F12 medium containing 5% (v/v) calf serum and adjust the concentration of the cell suspension to 2×10 5 cells/ml, inoculate 100ml tissue culture bottles at 10ml/bottle, and inoculate 7 Culture flasks were cultured statically at 37°C, 5% CO 2 . Except that the above-mentioned serum-free medium was replaced by the F12 medium containing 5% (v/v) calf serum, the culture and counting methods of HEK293 cells were the same as the above-mentioned method, which was used as the control of the embodiment. After 4 days of culture, the morphology of HEK293 cells in F12 medium containing 5% (v/v) calf serum was the same as that of HEK293 cells cultured in serum-free medium (Fig. 1B). The growth kinetics and cell density of HEK293 cells in the serum-free medium were comparable to their culture effects in the F12 medium containing 5% (v/v) calf serum as a control in the example ( FIG. 2 ).
实施例2、在5L搅拌罐式生物反应器中连续灌注培养HEK293细胞Example 2, HEK293 cells were cultured by continuous perfusion in a 5L stirred tank bioreactor
将在2000ml转瓶中用表2所列的无血清培养基培养的HEK293细胞用0.25%(w/v)的胰蛋白酶室温下消化2min。用表3列的无血清培养基分散细胞并接种于工作体积为5L、装备有内置式旋转滤器的搅拌罐式生物反应器内(德国B.Braun Biotecn International公司),接种密度为4.5×105cells/ml。温度设置为37℃、溶解氧浓度控制在30~50%、pH控制在7.1~7.2。搅拌速度在培养的第1~3天设置为35~50r/min,使HEK293细胞相互聚集、形成细胞团,从第4天起,根据HEK293细胞团的平均粒径变化,在50~120r/min的范围内逐步提高搅拌速度。HEK293 cells cultured in a 2000 ml spinner bottle with the serum-free medium listed in Table 2 were digested with 0.25% (w/v) trypsin at room temperature for 2 min. Use the serum-free medium listed in Table 3 to disperse the cells and inoculate them in a stirred tank bioreactor with a working volume of 5 L and equipped with a built-in rotary filter (B. Braun Biotecn International, Germany), with an inoculation density of 4.5×10 5 cells/ml. The temperature was set at 37°C, the dissolved oxygen concentration was controlled at 30-50%, and the pH was controlled at 7.1-7.2. The stirring speed is set at 35-50r/min on the 1st-3rd day of culture to make the HEK293 cells aggregate each other and form cell clusters. From the 4th day, according to the change of the average particle size of the HEK293 cell Gradually increase the stirring speed within the range.
表3在5L生物反应器中灌注培养HEK293细胞的无血清培养基Table 3 Serum-free medium for perfusion culture of HEK293 cells in 5L bioreactor
每天取样用YSI 7100型多参数生物分析系统(YSI 7100,Yellow Springs Instruments)检测培养基中的葡萄糖和乳酸浓度,用Cedex A20测定细胞密度和细胞活力。培养1天后,启动生物反应器的培养基灌注系统,利用生物反应器中微孔径为75μm的内置式旋转过滤器截流细胞团,根据细胞密度和葡萄糖浓度将灌注速率调整为0.15~1.5volume/day,实施HEK293细胞的无血清连续灌注培养操作。Samples were taken every day with YSI 7100 multi-parameter bioanalysis system (YSI 7100, Yellow Springs Instruments) to detect the concentration of glucose and lactic acid in the medium, and Cedex A20 was used to measure cell density and cell viability. After culturing for 1 day, start the medium perfusion system of the bioreactor, use the built-in rotary filter with a micropore diameter of 75 μm in the bioreactor to intercept the cell mass, and adjust the perfusion rate to 0.15-1.5 volume/day according to the cell density and glucose concentration , implement serum-free continuous perfusion culture operation of HEK293 cells.
整个培养过程持续17天,HEK293细胞的密度由接种时的4.5×105cells/ml增加到的培养结束时的13.7×106cells/ml,HEK293细胞的活力在整个培养过程中保持在大于90%的水平(图3)。HEK293细胞的形状在流体动力作用下形成形状相对规整、大小相对均一的球状细胞团(图4)。The whole culture process lasted for 17 days, the density of HEK293 cells increased from 4.5×10 5 cells/ml at the time of inoculation to 13.7×10 6 cells/ml at the end of culture, and the viability of HEK293 cells remained at more than 90 during the whole culture process. % level (Figure 3). The shape of HEK293 cells forms spherical cell clusters with relatively regular shape and relatively uniform size under the action of hydrodynamic force (Figure 4).
本发明的特定实施例已经对本发明的内容做了详尽的说明。对本领域的一般技术人员而言,在不背离本发明精神的前提下对它所做的任何显而易见的改动,特别是对若干步骤的等同替换,都构成对本发明专利权的侵犯,将承担相应的法律责任。Specific embodiments of the present invention have described the content of the present invention in detail. For those of ordinary skill in the art, any obvious changes made to it without departing from the spirit of the present invention, especially the equivalent replacement of several steps, constitute an infringement of the patent right of the present invention, and will bear the corresponding legal liability.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101090504A CN100348718C (en) | 2005-10-18 | 2005-10-18 | Culture medium without animal originating component and serum for HEK293 cell adhesion culture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101090504A CN100348718C (en) | 2005-10-18 | 2005-10-18 | Culture medium without animal originating component and serum for HEK293 cell adhesion culture |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1772884A CN1772884A (en) | 2006-05-17 |
CN100348718C true CN100348718C (en) | 2007-11-14 |
Family
ID=36760024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101090504A Expired - Fee Related CN100348718C (en) | 2005-10-18 | 2005-10-18 | Culture medium without animal originating component and serum for HEK293 cell adhesion culture |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100348718C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103484426A (en) * | 2013-10-15 | 2014-01-01 | 齐鲁制药有限公司 | Non-animal source low-protein culture medium |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101864393B (en) * | 2009-05-06 | 2012-04-04 | 中国人民解放军军事医学科学院生物工程研究所 | Serum-free culture medium without animal origin components for culturing Vero cell micro-carrier |
CN101864391B (en) * | 2010-05-18 | 2012-11-28 | 博格隆(上海)生物技术有限公司 | Microcarrier for culturing animal cell and crosslinking method thereof |
CN102604889B (en) * | 2012-03-19 | 2013-05-08 | 中国农业科学院哈尔滨兽医研究所 | HEK (human embryonic kidney) 293 cell line applicable to serum-free culture and application thereof |
CN103421736B (en) * | 2012-05-21 | 2014-12-17 | 中国人民解放军军事医学科学院生物工程研究所 | Medium additive replacing animal serum in CHO cell culture and preparation method thereof |
HUE037482T2 (en) * | 2013-01-08 | 2018-08-28 | Genzyme Corp | Use of Inos inhibitors to increase virus yield in culture |
CN104651297A (en) * | 2013-11-19 | 2015-05-27 | 华东师范大学 | Culture medium used in high-density large-scale suspended cultivation of human embryo nephrocyte, preparation method and application thereof |
CN104450607B (en) * | 2014-11-14 | 2017-07-11 | 武汉金开瑞生物工程有限公司 | For the full chemistry culture medium and cultural method of HEK293 cell suspension growths |
CN108004202B (en) * | 2017-12-15 | 2021-07-02 | 济南赛尔生物科技股份有限公司 | Culture solution for serum-free suspension culture of 293T cells |
CN110835622B (en) * | 2018-08-16 | 2021-04-27 | 上海药明生物技术有限公司 | Culture medium for regulating lactic acid metabolism of mammalian cells and application thereof |
CN111304149B (en) * | 2020-02-21 | 2022-07-05 | 新乡医学院 | A serum-free protein-free medium supporting HEK293 cell suspension culture and its preparation method and application |
CN111826341A (en) * | 2020-07-23 | 2020-10-27 | 上海奥浦迈生物科技有限公司 | Method for in vitro culture of HEK293 cells for transient expression of proteins |
CN115537378B (en) * | 2022-11-24 | 2023-05-19 | 天信和(苏州)生物科技有限公司 | Method for suspension culture of HEK293 cells and culture medium thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362514A (en) * | 2002-01-25 | 2002-08-07 | 华东理工大学 | Serumless medium suitable for growth and maintenance of young hamster kidney cell |
CN1570090A (en) * | 2004-05-11 | 2005-01-26 | 戴育成 | Cell suspension culture and anchorage culture serum free medium and its preparation method |
-
2005
- 2005-10-18 CN CNB2005101090504A patent/CN100348718C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362514A (en) * | 2002-01-25 | 2002-08-07 | 华东理工大学 | Serumless medium suitable for growth and maintenance of young hamster kidney cell |
CN1570090A (en) * | 2004-05-11 | 2005-01-26 | 戴育成 | Cell suspension culture and anchorage culture serum free medium and its preparation method |
Non-Patent Citations (1)
Title |
---|
动物细胞无血清培养基及其应用 陈昭烈等.生物工程进展,第14卷第5期 1994 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103484426A (en) * | 2013-10-15 | 2014-01-01 | 齐鲁制药有限公司 | Non-animal source low-protein culture medium |
CN103484426B (en) * | 2013-10-15 | 2014-11-26 | 齐鲁制药有限公司 | Non-animal source low-protein culture medium |
Also Published As
Publication number | Publication date |
---|---|
CN1772884A (en) | 2006-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Leber et al. | Microcarrier choice and bead-to-bead transfer for human mesenchymal stem cells in serum-containing and chemically defined media | |
Fernandes et al. | Mouse embryonic stem cell expansion in a microcarrier-based stirred culture system | |
CN100348718C (en) | Culture medium without animal originating component and serum for HEK293 cell adhesion culture | |
CN101724600B (en) | Blood serum-free culture medium for supporting suspension culture of CHO cells with large scale and high density | |
CN101864393B (en) | Serum-free culture medium without animal origin components for culturing Vero cell micro-carrier | |
Schroeder et al. | Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control | |
KR101885046B1 (en) | Method of producing a polypeptide or virus of interest in a continuous cell culture | |
CN101760442B (en) | Serum-free medium for MDCK cell large-scale adherent culture and single-cell suspension culture | |
CN102827804A (en) | Culture medium applicable to suspension and magnification cultivation of Vero cell microcarriers and method for suspension magnification cultivation of Vero cell microcarriers | |
CN112048470B (en) | Method for preparing clinical grade mesenchymal stem cell preparation by using human induced pluripotent stem cells | |
EP3963050B1 (en) | Preparation of human allogeneic liver-derived progenitor cells | |
Landauer | Designing media for animal cell culture: CHO cells, the industrial standard | |
WO2024251234A1 (en) | Serum-free culture medium for mesenchymal stem cells and use thereof | |
Zhou et al. | Ex vivo expansion of bone marrow mesenchymal stem cells using microcarrier beads in a stirred bioreactor | |
CN1962857A (en) | Serum-free medium for mammalian cell | |
CN1238495C (en) | Aimal cell multipore micro carrier immobilized high efficiency culturing method and its culturing medium | |
US20220220445A1 (en) | Preparation of human allogeneic liver-derived progenitor cells | |
CN113881621B (en) | Embryonic stem cell culture medium and its preparation method and application | |
CN103421736B (en) | Medium additive replacing animal serum in CHO cell culture and preparation method thereof | |
US20150329826A1 (en) | Materials and methods for cell culture | |
CN102653729B (en) | Culture medium used for Chinese hamster ovary cells | |
CN110951686A (en) | Hematopoietic stem cell in-vitro amplification culture system and method | |
Santos et al. | Scaling-up ex vivo expansion of mesenchymal stem/stromal cells for cellular therapies | |
Schrimpf et al. | Growth of human vascular endothelial cells on various types of microcarriers | |
KR20230026433A (en) | Methods and compositions for culturing pluripotent cell suspensions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071114 Termination date: 20141018 |
|
EXPY | Termination of patent right or utility model |